Symbols / PTGX Stock $100.88 +2.55% Protagonist Therapeutics, Inc.

Healthcare • Biotechnology • United States • NGM
PTGX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index
Sector Healthcare
Industry Biotechnology
CEO
Exch · Country NGM · United States
Market Cap 6.32B
Enterprise Value
Income
Sales
FCF (ttm)
Book/sh
Cash/sh
Employees
Insider 10d
IPO
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout
P/E
Forward P/E
PEG
P/S
P/B
P/C
EV/EBITDA
EV/Sales
Quick Ratio
Current Ratio
Debt/Eq
LT Debt/Eq
EPS (ttm)
EPS next Y
EPS Growth
Revenue Growth
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next)
Earnings (prior)
ROA
ROE
ROIC
Gross Margin
Oper. Margin
Profit Margin
Shs Outstand
Shs Float
Insider Own
Instit Own
Short Float
Short Ratio
Short Interest
52W High
vs 52W High
52W Low
vs 52W Low
Beta
Impl. Vol.
Rel Volume
Avg Volume
Volume
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom
Prev Close $98.37
Price $100.88
Change 2.55%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified FCF or EPS-based estimate
Ratings
Current target
Low
High
Mean
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
46.02
-89.41%
434.43
+624.06%
60.00
+125.73%
26.58
Operating Revenue
46.02
-89.41%
434.43
+624.06%
60.00
+125.73%
26.58
Operating Expense
204.14
+12.42%
181.59
+18.18%
153.65
-2.72%
157.95
Research And Development
159.29
+15.32%
138.13
+14.95%
120.16
-4.80%
126.22
Selling General And Administration
44.85
+3.20%
43.46
+29.77%
33.49
+5.52%
31.74
General And Administrative Expense
44.85
+3.20%
43.46
+29.77%
33.49
+5.52%
31.74
Other Gand A
44.85
+3.20%
43.46
+29.77%
33.49
+5.52%
31.74
Total Expenses
204.14
+12.42%
181.59
+18.18%
153.65
-2.72%
157.95
Operating Income
-158.13
-162.54%
252.84
+369.98%
-93.65
+28.71%
-131.37
Total Operating Income As Reported
-158.13
-162.54%
252.84
+369.98%
-93.65
+28.71%
-131.37
EBITDA
-156.85
-161.83%
253.67
+373.72%
-92.67
+28.90%
-130.34
Normalized EBITDA
-156.85
-161.83%
253.67
+373.72%
-92.67
+28.90%
-130.34
Reconciled Depreciation
1.28
+54.96%
0.83
-15.46%
0.98
-5.51%
1.03
EBIT
-158.13
-162.54%
252.84
+369.98%
-93.65
+28.71%
-131.37
Total Unusual Items
0.00
Total Unusual Items Excluding Goodwill
0.00
Special Income Charges
0.00
Net Income
-130.15
-147.29%
275.19
+448.54%
-78.95
+38.02%
-127.39
Pretax Income
-129.31
-146.28%
279.41
+453.88%
-78.95
+38.02%
-127.39
Net Non Operating Interest Income Expense
28.79
+9.40%
26.32
+76.63%
14.90
+266.95%
4.06
Interest Expense Non Operating
0.00
Net Interest Income
28.79
+9.40%
26.32
+76.63%
14.90
+266.95%
4.06
Interest Expense
0.00
Interest Income Non Operating
28.79
+9.40%
26.32
+76.63%
14.90
+266.95%
4.06
Interest Income
28.79
+9.40%
26.32
+76.63%
14.90
+266.95%
4.06
Other Income Expense
0.03
-89.20%
0.25
+224.38%
-0.20
-151.25%
-0.08
Other Non Operating Income Expenses
0.03
-89.20%
0.25
+224.38%
-0.20
-151.25%
-0.08
Tax Provision
0.84
-80.14%
4.22
0.00
0.00
Tax Rate For Calcs
0.00
+1300.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-130.15
-147.29%
275.19
+448.54%
-78.95
+38.02%
-127.39
Net Income From Continuing Operation Net Minority Interest
-130.15
-147.29%
275.19
+448.54%
-78.95
+38.02%
-127.39
Net Income From Continuing And Discontinued Operation
-130.15
-147.29%
275.19
+448.54%
-78.95
+38.02%
-127.39
Net Income Continuous Operations
-130.15
-147.29%
275.19
+448.54%
-78.95
+38.02%
-127.39
Normalized Income
-130.15
-147.29%
275.19
+448.54%
-78.95
+38.02%
-127.39
Net Income Common Stockholders
-130.15
-147.29%
275.19
+448.54%
-78.95
+38.02%
-127.39
Diluted EPS
-2.05
-148.46%
4.23
+404.32%
-1.39
+46.54%
-2.60
Basic EPS
-2.05
-145.86%
4.47
+421.58%
-1.39
+46.54%
-2.60
Basic Average Shares
63.57
+3.26%
61.57
+8.46%
56.76
+15.74%
49.04
Diluted Average Shares
63.57
-2.31%
65.08
+14.65%
56.76
+15.74%
49.04
Diluted NI Availto Com Stockholders
-130.15
-147.29%
275.19
+448.54%
-78.95
+38.02%
-127.39
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
668.19
-10.28%
744.73
+108.05%
357.95
+44.38%
247.93
Current Assets
577.57
-2.38%
591.64
+66.39%
355.58
+46.28%
243.08
Cash Cash Equivalents And Short Term Investments
567.36
+35.44%
418.91
+22.63%
341.62
+43.93%
237.35
Cash And Cash Equivalents
128.39
+32.02%
97.25
-47.92%
186.73
+48.50%
125.74
Other Short Term Investments
438.97
+36.47%
321.66
+107.67%
154.89
+38.78%
111.61
Receivables
4.50
-97.33%
168.49
+1530.76%
10.33
+19769.23%
0.05
Other Receivables
0.01
-95.97%
0.25
+226.32%
0.08
+80.95%
0.04
Taxes Receivable
0.00
Accrued Interest Receivable
4.37
+34.64%
3.24
+1166.41%
0.26
Prepaid Assets
5.71
+34.83%
4.24
+16.81%
3.63
-36.01%
5.67
Restricted Cash
Other Current Assets
0.04
Total Non Current Assets
90.61
-40.81%
153.08
+6348.36%
2.37
-51.06%
4.85
Net PPE
11.69
-7.28%
12.61
+486.64%
2.15
-53.55%
4.63
Gross PPE
20.00
+1.84%
19.64
+134.31%
8.38
-15.15%
9.88
Accumulated Depreciation
-8.31
-18.19%
-7.04
-12.85%
-6.23
-18.65%
-5.25
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.49
+3.04%
1.45
+26.60%
1.14
+4.96%
1.09
Other Properties
15.58
-1.23%
15.77
+151.25%
6.28
-20.32%
7.88
Leases
2.94
+21.12%
2.42
+151.71%
0.96
+5.48%
0.91
Investments And Advances
78.64
-43.93%
140.25
0.00
Other Non Current Assets
0.29
+27.56%
0.23
+0.00%
0.23
+0.00%
0.23
Total Liabilities Net Minority Interest
53.48
-22.97%
69.43
+226.36%
21.27
-34.18%
32.32
Current Liabilities
45.44
-4.13%
47.40
+122.80%
21.27
-31.77%
31.18
Payables And Accrued Expenses
20.84
+23.20%
16.92
+26.79%
13.34
-43.52%
23.63
Payables
5.52
+26.18%
4.38
+402.64%
0.87
-78.52%
4.05
Accounts Payable
5.34
+230.59%
1.61
+109.20%
0.77
-78.79%
3.64
Other Payable
0.18
+150.00%
0.07
-25.25%
0.10
-76.14%
0.41
Current Accrued Expenses
15.32
+22.16%
12.54
+0.55%
12.47
-36.27%
19.57
Pensionand Other Post Retirement Benefit Plans Current
12.76
+15.22%
11.08
+63.25%
6.79
+36.62%
4.97
Total Tax Payable
0.00
-100.00%
2.69
0.00
Income Tax Payable
0.00
-100.00%
2.69
0.00
Current Debt And Capital Lease Obligation
2.28
+347.65%
0.51
-55.30%
1.14
-54.63%
2.52
Current Capital Lease Obligation
2.28
+347.65%
0.51
-55.30%
1.14
-54.63%
2.52
Current Deferred Liabilities
9.55
-49.45%
18.89
+629600.00%
0.00
-95.65%
0.07
Current Deferred Revenue
9.55
-49.45%
18.89
+629600.00%
0.00
-95.65%
0.07
Total Non Current Liabilities Net Minority Interest
8.04
-63.51%
22.03
0.00
-100.00%
1.14
Long Term Debt And Capital Lease Obligation
8.04
-22.36%
10.36
0.00
-100.00%
1.14
Long Term Capital Lease Obligation
8.04
-22.36%
10.36
0.00
-100.00%
1.14
Non Current Deferred Liabilities
0.00
-100.00%
11.68
0.00
Stockholders Equity
614.71
-8.97%
675.29
+100.58%
336.68
+56.15%
215.61
Common Stock Equity
614.71
-8.97%
675.29
+100.58%
336.68
+56.15%
215.61
Capital Stock
0.00
+0.00%
0.00
+0.00%
0.00
0.00
Common Stock
0.00
+0.00%
0.00
+0.00%
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
62.58
+2.53%
61.04
+5.76%
57.71
+16.96%
49.34
Ordinary Shares Number
62.58
+2.53%
61.04
+5.76%
57.71
+16.96%
49.34
Additional Paid In Capital
1,084.74
+6.78%
1,015.90
+6.66%
952.49
+26.54%
752.72
Retained Earnings
-470.67
-38.22%
-340.52
+44.69%
-615.71
-14.71%
-536.75
Gains Losses Not Affecting Retained Earnings
0.64
+881.71%
-0.08
+21.90%
-0.10
+70.75%
-0.36
Other Equity Adjustments
0.64
+881.71%
-0.08
+21.90%
-0.10
+70.75%
-0.36
Total Equity Gross Minority Interest
614.71
-8.97%
675.29
+100.58%
336.68
+56.15%
215.61
Total Capitalization
614.71
-8.97%
675.29
+100.58%
336.68
+56.15%
215.61
Working Capital
532.13
-2.23%
544.24
+62.80%
334.30
+57.77%
211.90
Invested Capital
614.71
-8.97%
675.29
+100.58%
336.68
+56.15%
215.61
Total Debt
10.32
-5.00%
10.87
+852.32%
1.14
-68.79%
3.66
Capital Lease Obligations
10.32
-5.00%
10.87
+852.32%
1.14
-68.79%
3.66
Net Tangible Assets
614.71
-8.97%
675.29
+100.58%
336.68
+56.15%
215.61
Tangible Book Value
614.71
-8.97%
675.29
+100.58%
336.68
+56.15%
215.61
Duefrom Related Parties Current
0.12
-99.93%
165.00
+1550.00%
10.00
+99900.00%
0.01
Dueto Related Parties Current
0.07
Investmentin Financial Assets
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
57.67
-68.68%
184.15
+362.19%
-70.24
+35.05%
-108.14
Cash Flow From Continuing Operating Activities
57.67
-68.68%
184.15
+362.19%
-70.24
+35.05%
-108.14
Net Income From Continuing Operations
-130.15
-147.29%
275.19
+448.54%
-78.95
+38.02%
-127.39
Depreciation Amortization Depletion
1.28
+54.96%
0.83
-15.46%
0.98
-5.51%
1.03
Depreciation
1.28
+54.96%
0.83
-15.46%
0.98
-5.51%
1.03
Depreciation And Amortization
1.28
+54.96%
0.83
-15.46%
0.98
-5.51%
1.03
Other Non Cash Items
1.58
-23.63%
2.07
-18.19%
2.53
+8.31%
2.33
Stock Based Compensation
45.97
+22.42%
37.55
+28.20%
29.29
+21.04%
24.20
Deferred Tax
0.00
Deferred Income Tax
0.00
Gain Loss On Sale Of PPE
Change In Working Capital
146.21
+219.25%
-122.61
-528.41%
-19.51
-151.24%
-7.77
Change In Receivables
164.88
+206.37%
-155.00
-1451.55%
-9.99
-335.50%
4.24
Change In Prepaid Assets
-2.36
+37.37%
-3.77
-314.95%
1.75
-53.30%
3.75
Change In Payables And Accrued Expense
5.61
-28.23%
7.82
+191.63%
-8.53
+25.82%
-11.50
Change In Accrued Expense
4.58
+6.69%
4.29
+176.63%
-5.60
+55.98%
-12.71
Change In Payable
1.03
-70.69%
3.53
+220.25%
-2.93
-341.48%
1.22
Change In Account Payable
3.72
+342.16%
0.84
+129.36%
-2.87
-240.24%
2.04
Change In Other Working Capital
-21.02
-168.76%
30.57
-1.60
Change In Other Current Liabilities
-0.90
+59.43%
-2.23
+18.85%
-2.74
-3.08%
-2.66
Investing Cash Flow
-49.33
+83.53%
-299.48
-662.86%
-39.26
-142.92%
91.47
Cash Flow From Continuing Investing Activities
-49.33
+83.53%
-299.48
-662.86%
-39.26
-142.92%
91.47
Net PPE Purchase And Sale
-1.59
-17.34%
-1.35
-122.50%
-0.61
+23.40%
-0.80
Purchase Of PPE
-1.59
-17.34%
-1.35
-122.50%
-0.61
+23.40%
-0.80
Capital Expenditure
-1.59
-17.34%
-1.35
-122.50%
-0.61
+23.40%
-0.80
Net Investment Purchase And Sale
-47.74
+83.99%
-298.13
-671.37%
-38.65
-141.89%
92.26
Purchase Of Investment
-546.59
+12.08%
-621.70
-225.42%
-191.04
+11.09%
-214.87
Sale Of Investment
498.84
+54.17%
323.57
+112.32%
152.40
-50.38%
307.14
Financing Cash Flow
22.86
-11.56%
25.85
-84.83%
170.48
+804.96%
18.84
Cash Flow From Continuing Financing Activities
22.86
-11.56%
25.85
-84.83%
170.48
+804.96%
18.84
Net Issuance Payments Of Debt
0.00
Issuance Of Debt
Repayment Of Debt
0.00
Long Term Debt Issuance
Long Term Debt Payments
0.00
Net Long Term Debt Issuance
0.00
Net Common Stock Issuance
0.00
0.00
-100.00%
132.10
+807.72%
14.55
Proceeds From Stock Option Exercised
23.34
-11.76%
26.45
-32.42%
39.15
+780.08%
4.45
Net Other Financing Charges
-0.48
+20.17%
-0.60
+21.98%
-0.77
-371.78%
-0.16
Changes In Cash
31.20
+134.87%
-89.48
-246.73%
60.98
+2711.57%
2.17
Effect Of Exchange Rate Changes
0.00
0.00
+100.00%
-0.09
Beginning Cash Position
97.47
-47.86%
186.95
+48.41%
125.97
+1.68%
123.89
End Cash Position
128.68
+32.01%
97.47
-47.86%
186.95
+48.41%
125.97
Free Cash Flow
56.08
-69.32%
182.80
+358.02%
-70.84
+34.96%
-108.93
Interest Paid Supplemental Data
3.69
+141.44%
1.53
0.00
0.00
Amortization Of Securities
-7.22
+18.61%
-8.88
-94.24%
-4.57
-732.24%
-0.55
Change In Income Tax Payable
-2.69
-200.00%
2.69
0.00
0.00
Change In Tax Payable
-2.69
-200.00%
2.69
0.00
0.00
Common Stock Issuance
0.00
0.00
-100.00%
132.10
+807.72%
14.55
Issuance Of Capital Stock
0.00
0.00
-100.00%
132.10
+807.72%
14.55
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category